Summarize this content to 100 words The FDA has granted Visby Medical authorization to market their at-home, over-the-counter diagnostic test that detects chlamydia, gonorrhea and trichomoniasis, according to a press release.The Women’s Sexual Health Test (Visby Medical) is intended for women regardless of symptom status and delivers results in approximately 30 minutes using a vaginal swab, the FDA said in the release.The main risk individuals using the test should be aware of is the possibility of false positive and false negative results, according to the release.“Home tests can give people information about their
Source link
FDA authorizes marketing of first chlamydia, gonorrhea, trichomoniasis home test
